Custom Drug Profiling
Horizon is pleased to be able to offer its customers a special Q4, 08 offer for screening of compounds against eight of its single and double knock-in genotypes.
- Normal breast epithelium - parental cell line
- Normal breast epithelium - PIK3C
- Normal breast epithelium - EGFR
- Normal breast epithelium - K-Ras
- Normal breast epithelium - B-Raf
- Normal breast epithelium - PIK3C/EGRF double
- Normal breast epithelium - K-Ras/PIK3CA double
- Normal breast epithelium - EGFR /B-Raf double
The assay would be formatted to our standard proliferation assay (or nominated customer alternative) with a 10point x 3 replicte dose response performed. All data will be presented in an industry standard reporting format.
For a limited period (due to extensive internal and commercial screening work currently being performed on this panel), Horizon is able to offer customers upto 40% discount from that charged via our standard pricing tariff,
